Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsIMPLANTATIONGeneric

NORPLANT

LEVONORGESTREL

Standard Dose
36MG/IMPLANT
Max Dose
Refer to approved labeling
Primary Use
Review priority: PRIORITY Marketing status: Discontinued
Summary

Approval overview NORPLANT is listed in Drugs@FDA under application 019897 (NDA).

Review priority: PRIORITY Marketing status: Discontinued Active ingredient LEVONORGESTREL Form and strength IMPLANT;IMPLANTATION - 36MG/IMPLANT Sponsor POPULATION COUNCIL Submission history Latest submission status date: 2001-05-21 00:00:00.

Structured Monograph

Clinical summary

Approval overview NORPLANT is listed in Drugs@FDA under application 019897 (NDA). Review priority: PRIORITY Marketing status: Discontinued Active ingredient LEVONORGESTREL Form and strength IMPLANT;IMPLANTATION - 36MG/IMPLANT Sponsor POPULATION COUNCIL Submission history Latest submission status date: 2001-05-21 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: PRIORITY

Interaction Notes

  • No interaction notes stored yet.